Jingcheng Y. Zhang
Qingchun Street 79th
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Bilateral radial arterial pressure concordance as a real-time bedside marker of native cardiac recovery during peripheral VA-ECMO weaning.
Journal: Critical care (London, England)
Published: May 31, 2026
A prospective, phase IV study of ixazomib, pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma.
Journal: British journal of haematology
Published: March 27, 2026
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group.
Journal: American journal of hematology
Published: December 12, 2025
Identification of prospective novel drug targets for immune thrombocytopenia by integrating plasma proteome.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 14, 2025
Zanubrutinib, Lenalidomide, and Rituximab Demonstrate Efficacy in Relapsed/Refractory Central Nervous System Lymphoma: A Single - Center Retrospective Study.
Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: March 28, 2025
SENP5 acts as a downstream target of androgen receptor and contributes to prostate cancer growth.
Journal: Oncology letters
Published: November 19, 2024
Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminase.
Journal: Journal of cancer research and clinical oncology
Published: August 13, 2024
Nomogram establishment for short-term survival prediction in ICU patients with aplastic anemia based on the MIMIC-IV database.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 16, 2024
Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3+ T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome Patients.
Journal: Frontiers in oncology
Published: July 14, 2021
Comparison of efficacy of HCAG and CAG re-induction chemotherapy in elderly low- and intermediate-risk group patients diagnosed with acute myeloid leukemia.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 28, 2020
Last Updated: 09/26/2026